A detailed history of Prostatis Group LLC transactions in Schwab Strategic Tr Us Dividen stock. As of the latest transaction made, Prostatis Group LLC holds 65,779 shares of SCHD stock, worth $1.88 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
65,779
Holding current value
$1.88 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$69.18 - $73.94 $4.55 Million - $4.86 Million
65,779 New
65,779 $75.2 Million
Q3 2022

Mar 23, 2023

SELL
$66.43 - $77.87 $2.1 Million - $2.47 Million
-31,668 Closed
0 $0
Q2 2022

Mar 23, 2023

SELL
$70.31 - $80.24 $2.98 Million - $3.4 Million
-42,331 Reduced 57.2%
31,668 $47.4 Million
Q1 2022

Mar 23, 2023

SELL
$75.14 - $81.94 $136,754 - $149,130
-1,820 Reduced 2.4%
73,999 $34.6 Million
Q4 2021

Mar 23, 2023

SELL
$74.93 - $80.86 $7.88 Million - $8.5 Million
-105,178 Reduced 58.11%
75,819 $75.8 Million
Q3 2021

Mar 23, 2023

BUY
$74.23 - $78.13 $13.4 Million - $14.1 Million
180,997 New
180,997 $181 Million

Others Institutions Holding SCHD

About SCHWAB STRATEGIC TR US DIVIDEN


  • Ticker SCHD
  • Sector ETFs
  • Industry ETFs
More about SCHD
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.